Development and Implementation of Pharmacist-based Diabetic Intervention Model in type-2 diabetes patients in Pakistan: A randomized controlled trial

Not Applicable

Active, not recruiting

• Conditions: Diabetes mellitus; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12619001618145
• Lead Sponsor: Tauqeer Hussain

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-11-22
• Last Update Posted: 6 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

Type-2 diabetes mellitus

Exclusion Criteria

Pregnancy
Juvenile Type Diabetes
Type-1 diabetes
Dementia

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HbA1C<br>by Serum assay[180 days];Medication adherence by Morisky Medication Adherence Scale (MMAS)[180 days];Health Related Quality of Life<br>by Euro Qol EQ-5D-5L[180 days]

Secondary Outcome Measures

Name	Time	Method
Blood pressure<br>by using automated machine[180 days];Lipid Profile (Triglycerides, cholesterol, HDL, LDL)<br>by serum assay[180 days];Body Fats<br>by using Fat analyzer machine[180 days];BMI<br>by using fat analyzer machine (Omron Fat analyzer Model: BF508)<br>A stadiometer will used to assess height in centimeters.[180 days]